These data are the first to demonstrate that SOCS3 antagonizes both leptin and insulin signaling in skeletal muscle, which is a principal site of glucose and fatty acid use and is one of the primary tissues responsible for insulin resistance in obesity [5]. The gene discussed is SOCS3; the disease is obesity due to melanocortin 4 receptor deficiency.